Share chart ACADIA Pharmaceuticals Inc.
Extended chart
Simple chart
About ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc., биофармацевтическая компания, специализируется на разработке и коммерциализации низкомолекулярных препаратов, предназначенных для удовлетворения неудовлетворенных медицинских потребностей при заболеваниях центральной нервной системы. more details| IPO date | 2004-05-27 |
|---|---|
| ISIN | US0042251084 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | https://www.acadia-pharm.com |
| Цена ао | 16.94 |
| Change price per day: | -0.6743% (14.83) |
|---|---|
| Change price per week: | 0% (14.73) |
| Change price per month: | -13.51% (17.03) |
| Change price per 3 month: | -21.1% (18.67) |
| Change price per half year: | -0.0678% (14.74) |
| Change price per year: | -11.85% (16.71) |
| Change price per 3 year: | -13.91% (17.11) |
| Change price per 5 year: | -65.95% (43.26) |
| Change price per 10 year: | -61.24% (38) |
| Change price per year to date: | -19.73% (18.35) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Baker Brothers Advisors, LLC | 42864612 | 26.01 |
| Vanguard Group Inc | 13396009 | 8.13 |
| Blackrock Inc. | 11410483 | 6.93 |
| RTW Investments LP | 11253551 | 6.83 |
| State Street Corporation | 6465026 | 3.92 |
| EcoR1 Capital, LLC | 5991479 | 3.64 |
| FMR, LLC | 5265358 | 3.2 |
| Price (T.Rowe) Associates Inc | 5178509 | 3.14 |
| Shaw D.E. & Co., Inc. | 3754598 | 2.28 |
| Fred Alger Management, LLC | 3176775 | 1.93 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| PSYK ETF | 4.28 | 0 | |
| Future Tech ETF | 0.26494 | 426.34 | 0.8416 |
| Principal Healthcare Innovators ETF | 0.26494 | 618.5 | 0.8416 |
| Donoghue Forlines Innovation ETF | 0.20684 | 10.06 | 0.89556 |
| iShares Morningstar Small-Cap Growth ETF | 0.08563 | 596.94 | 0.72598 |
| iShares Morningstar Small-Cap ETF | 0.04331 | 391.25 | 1.60498 |
| 0.86 | 340.51 | 0.82 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. James K. Kihara | VP, Chief Accounting Officer & Corporate Controller | N/A | 1981 (44 years) |
| Mr. Stephen R. Davis J.D. | President, CEO & Director | 1.46M | 1961 (64 years) |
| Mr. Mark C. Schneyer | Executive VP & CFO | 701.03k | 1974 (51 year) |
| Mr. Brendan P. Teehan | Executive VP, COO & Head of Commercial | 724.31k | 1969 (56 years) |
| Mr. Rob Ackles | Senior VP & Chief People Officer | N/A | |
| Ms. Holly Valdiviez | Senior VP & Head of Sales | N/A | |
| Mr. Albert S. Kildani | Senior Vice President of Investor Relations & Corporate Communications | N/A | |
| Mr. Benir Ruano | Senior Vice President of Technical Development & Operations | N/A | |
| Ms. Jennifer J. Rhodes J.D. | Executive VP, Chief Legal Officer & Secretary | N/A | 1970 (55 years) |
| Dr. Elizabeth H.Z. Thompson Ph.D. | Executive VP and Head of Research & Development | 1975 (50 years) |
Address: United States, San Diego, 12830 El Camino Real - open in Google maps, open in Yandex maps
Website: https://www.acadia-pharm.com
Website: https://www.acadia-pharm.com
